Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas

ConditionGlioma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Ulm

About this trial

The LoG-Glio-Registry is based on a network of german hospitals gathering radiological, clinical, epidemiological and molecular data on all patients diagnosed with a low grade glioma.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with radiological suspected diagnosis of a low grade glioma

Age ≥ 18 years. There is no upper age limit.

Disqualifiers

Severe neurological or psychiatric disorder interfering with ability to give an informed consent

No consent for registration, storage and processing of the individual disease characteristics and course as well as information of the family physician about study participation

No consent for bio-banking of patient's biological specimens and performance of analyses on stored material.

Trial population

All adult patients with radiological suspected diagnosis of a low grade glioma

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • no interventions

    Other intervention

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Progression-free survival (PFS)

Time frame
5yrs
2

Overall survival (OS)

Time frame
15yrs

Secondary outcomes

1

Extent of tumor resection

calculated based on volumetric assessement of tumor in cm³ and residual tumor in pre and postoperative MRI

Time frame
3yrs
2

Quality of life (QoL) assessed by the EORTC QLQ C-30/BN-20. (European Organisation for Research and Treatment of Cancer Quality of Life Questionaire C-30

Time frame
5yrs

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Ulm

Lead sponsor

Charite University, Berlin, Germany

Collaborator